Delivery Order SPE2DB20D2014-SPE2DB24FD10X
Award Date
9/20/24
Potential Completion Date
9/23/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,604.24 for the delivery of 4,565,471 units of the prescription drug Tamsulosin Hydrochloride 0.4 mg Capsules. The contract, issued by the Defense Logistics Agency (DLA), is a Delivery Order type with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,566,078,385 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $6,912.00 and a completion date of October 11, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,703.94, is a delivery order for the supply of 1,000 capsules of the medication Tamsulosin Hydrochloride 0.4 mg. The contract is a firm fixed-price agreement with a completion date of May 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,102,829 units of Tamsulosin HCl 0.4 mg capsules. The contract, a Firm Fixed Price Delivery Order, has a completion date of October 16, 2024 and a ceiling value of $16,332.76. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,245.66, is for the delivery of 4,563,322,760 capsules of Tamsulosin Hydrochloride 0.4 mg. This is a Firm Fixed Price delivery order contract with a completion date of January 16, 2024. The contract was awarded on January 12, 2024 and did not utilize any set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tamsulosin Hydrochloride 0.4 mg capsules. The contract is a Delivery Order with a Firm Fixed Price, valued at $2,328.19, and has an Ultimate Completion Date of August 15, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, through its Corporate Office division, will provide the medication to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,437.67, is for the delivery of 4,567,253 units of Tamsulosin HCL 0.4 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of February 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 4,566,422,443 units of Tamsulosin HCl 0.4 mg capsules. The contract, with a ceiling value of $1,547.94, was awarded by the Defense Logistics Agency (DLA) on November 13, 2024, with a completion date of November 14, 2024. It is a Firm Fixed Price Delivery Order contract type. AmerisourceBergen holds significant Indefinite Delivery Contracts...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,001,477 capsules of the generic drug tamsulosin hydrochloride 0.4 mg. The $3,324.39 contract has a performance period through March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract between...